
Gabapentin Lawsuit Filings Rise Over Dementia Injury Claims
What the new Philadelphia gabapentin docket covers, which diagnoses firms are screening for, and where the dementia science is genuinely contested.
Read more →
What the new Philadelphia gabapentin docket covers, which diagnoses firms are screening for, and where the dementia science is genuinely contested.
Read more →
The gabapentin dementia claims hinge on prescription counts and diagnosis age, not a lawsuit database or settlement fund to search.
Read more →
The six-prescription, pre-65-diagnosis screening rule for gabapentin dementia claims comes straight from a 2025 cohort study, not a court.
Read more →
Why Depo-Provera brain tumor payouts remain unofficial, who qualifies under the 2026 settlement, and the deadline claimants face.
Read more →
Purdue's bankruptcy consolidated opioid litigation into a single settlement process, creating a template for mass tort resolution that other defendants have since studied and...
Read more →
The company that manufactured OxyContin, the prescription opioid that fueled decades of addiction and overdose deaths, dissolved following a $7.4 billion...
Read more →
Pharmaceutical kickback lawsuits are civil and criminal cases alleging that drug manufacturers illegally paid healthcare providers—doctors, hospitals, and...
Read more →
A pharmaceutical manufacturing defect lawsuit is a legal claim alleging that a prescription drug or medical device was manufactured improperly, resulting...
Read more →
The Instagram self-harm lawsuit represents the first major jury trial testing whether social media platforms bear legal responsibility for mental health...
Read more →
Social media harm lawsuits are a growing category of mass tort litigation alleging that Meta (Facebook and Instagram), Google (YouTube), ByteDance...
Read more →
The Purdue Pharma opioid lawsuit settlement totals $7.4 billion, with U.S. Bankruptcy Judge Sean Lane formally approving the agreement in November 2025.
Read more →